Clinical TrialsSearch results
Number of results: 200
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) Study: Prospective Randomized Open-label Blinded Endpoint (PROBE)
- Untreated essential hypertensive patients
- HOMED-BP Study Group
- 2005-09-09
Other
- HLA gene polymorphisms and development of cervical cancer in a Japanese population; a case-control study
- Cervical cancer
- 'HLA gene polymorphisms and development of cervical cancer in a Japanese population; a case-control study' group
- 2008-05-16
Completed
- High-dose mizoribine with prednisolone therapy
- Nephrotic syndrome
- Nakanishi Koichi
- 2019-03-19
Completed
- Hesperidin (SHINJIMUN) blood perfusion trial
- N/A
- Inafuku Hitoshi
- 2020-10-13
Completed
- Hangeshashinto for refractory overactive bladder
- refractory overactive bladder
- Miyazato Minoru
- 2020-10-05
Other
- Gamma knife treatment results for patients with multiple brain metastases: A multi-institutional prospective study
- Metastatic brain tumor
- Japan Leksell Gamma Knife Society
- 2009-03-30
Other
- Feasibility study of TC(docetaxel+Cyclophosphamide)as adjuvant chemotherapy for intermediate risk primary breast cancer with HER2-negative and ER-positive tumor(KBC-SG 0803)
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2008-12-17
Other
- Feasibility study of Capecitabine as adjuvant chemotherapy for stage III colon cancer including RS cancer.
- stage III colon cancer including RS cancer
- KSCC
- 2008-10-22
Other
- Feasibility study of adjuvant chemotherapy with S-1 in elderly patients with non-small-cell lung cancer
- non-small-cell lung cancer
- Lung Oncology Group in Kyushu, Japan (LOGIK)
- 2009-08-25
Other
- Feasibility study of adjuvant chemotherapy consisting of FEC(fluoraouracil, epirubicin and cyclophosphamide) followed by DH(docetaxel+herceptin) for patients with HER2 positive breast cancer
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2008-12-17